Dorothy Yeboah-Manu | |
---|---|
Alma mater | London School of Hygiene & Tropical Medicine Swiss Tropical and Public Health Institute |
Awards | Royal Society Africa Prize 2018 |
Scientific career | |
Institutions | University of Ghana Noguchi Memorial Institute for Medical Research |
Dorothy Yeboah-Manu is a microbiologist and Professor at the Noguchi Memorial Institute for Medical Research at the University of Ghana. She studies host and pathogen interactions and epidemiology. She won the 2018 Royal Society Africa Prize.
Yeboah-Manu is from Akyem Abuakwa. [1] She completed a master's degree in Applied Molecular Biology of Infectious Diseases at the London School of Hygiene & Tropical Medicine. [2]
Yeboah-Manu joined the Noguchi Memorial Institute for Medical Research as a Research Assistant in 1993. She studied the safety of street food in Ghana. [3] [4] They found mesophilic bacteria in 69.7% of foods, including the staple foods fufu and omo tuo. [5] Yeboah-Manu was the first to describe polymorphism in the mycobacterium ulcerans from an African country and provide evidence to restrict Mycobacterium africanum to West Africa. [6] [7] She completed a PhD in medical parasitology and infection biology at the Swiss Tropical and Public Health Institute in 2006. [2] [8]
She was awarded a five-year Wellcome Trust fellowship in 2012, allowing her to work on mycobacterium tuberculosis. [9] She investigated the genomic diversity and differing profiles of gene expression between mycobacterium africanum and mycobacterium tuberculosis. [10] She is concerned about the fast spread of tuberculosis in Ghana's urban areas. [11]
She is on the National Faculty of the World Bank Centre of Excellence funded West African Centre for Cell Biology of Infectious Pathogens. [7] [12] [13] She is a member of the boards of the International Union Against Tuberculosis and Lung Disease, the World Health Organization Global Network of Laboratories Confirming Mycobacterium ulcerans Infection and the National Buruli Ulcer Control Program. [7] She is chair of the advisory board of the National Tuberculosis Program. [7] She is Vice President of the Immunological Society of Ghana. [2]
She has contributed to two books: Towards Effective Disease Control in Ghana: Research and Policy Implications Volume 1, Malaria and Volume 2, Other Infectious Diseases and Health Systems. [14] [15] She won the 2018 Royal Society Africa Prize. [16]
Mycobacterium tuberculosis, also known as Koch's bacillus, is a species of pathogenic bacteria in the family Mycobacteriaceae and the causative agent of tuberculosis. First discovered in 1882 by Robert Koch, M. tuberculosis has an unusual, waxy coating on its cell surface primarily due to the presence of mycolic acid. This coating makes the cells impervious to Gram staining, and as a result, M. tuberculosis can appear weakly Gram-positive. Acid-fast stains such as Ziehl–Neelsen, or fluorescent stains such as auramine are used instead to identify M. tuberculosis with a microscope. The physiology of M. tuberculosis is highly aerobic and requires high levels of oxygen. Primarily a pathogen of the mammalian respiratory system, it infects the lungs. The most frequently used diagnostic methods for tuberculosis are the tuberculin skin test, acid-fast stain, culture, and polymerase chain reaction.
Mycobacterium is a genus of over 190 species in the phylum Actinomycetota, assigned its own family, Mycobacteriaceae. This genus includes pathogens known to cause serious diseases in mammals, including tuberculosis and leprosy in humans. The Greek prefix myco- means 'fungus', alluding to this genus' mold-like colony surfaces. Since this genus has cell walls with a waxy lipid-rich outer layer that contains high concentrations of mycolic acid, acid-fast staining is used to emphasize their resistance to acids, compared to other cell types.
Mycobacterium bovis is a slow-growing aerobic bacterium and the causative agent of tuberculosis in cattle. It is related to Mycobacterium tuberculosis, the bacterium which causes tuberculosis in humans. M. bovis can jump the species barrier and cause tuberculosis-like infection in humans and other mammals.
Nontuberculous mycobacteria (NTM), also known as environmental mycobacteria, atypical mycobacteria and mycobacteria other than tuberculosis (MOTT), are mycobacteria which do not cause tuberculosis or leprosy. NTM do cause pulmonary diseases that resemble tuberculosis. Mycobacteriosis is any of these illnesses, usually meant to exclude tuberculosis. They occur in many animals, including humans and are commonly found in soil and water.
Buruli ulcer is an infectious disease characterized by the development of painless open wounds. The disease is limited to certain areas of the world, most cases occurring in Sub-Saharan Africa and Australia. The first sign of infection is a small painless nodule or area of swelling, typically on the arms or legs. The nodule grows larger over days to weeks, eventually forming an open ulcer. Deep ulcers can cause scarring of muscles and tendons, resulting in permanent disability.
Mycobacterium africanum is a species of Mycobacterium that is most commonly found in West African countries, where it is estimated to cause up to 40% of pulmonary tuberculosis. The symptoms of infection resemble those of M. tuberculosis.
The Royal Society Africa Prize has been awarded by the Royal Society since 2006 to African-based researchers at the start of their career who are making innovative contributions to the biological sciences in Africa. £60,000 is awarded as a grant for the recipient to carry out a research project that is linked to an African centre of scientific excellence, normally a University or equivalent research centre, and a further £5,000 is given directly to the prizewinner.
The Mycobacterium tuberculosis complex is a genetically related group of Mycobacterium species that can cause tuberculosis in humans or other animals.
Barry R. Bloom is Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health in Boston, where he served as dean of the faculty from 1998 through December 31, 2008.
Lalita Ramakrishnan is an Indian-born American microbiologist who is known for her contributions to the understanding of the biological mechanism of tuberculosis. As of 2019 she serves as a professor of Immunology and Infectious Diseases at the University of Cambridge, where she is also a Wellcome Trust Principal Research Fellow and a practicing physician. Her research is conducted at the MRC Laboratory of Molecular Biology, where she serves as the Head of the Molecular Immunity Unit of the Department of Medicine embedded at the MRC LMB. Working with Stanley Falkow at Stanford, she developed the strategy of using Mycobacterium marinum infection as a model for tuberculosis. Her work has appeared in a number of journals, including Science, Nature, and Cell. In 2018 and 2019 Ramakrishnan coauthored two influential papers in the British Medical Journal (BMJ) arguing that the widely accepted estimates of the prevalence of latent tuberculosis—estimates used as a basis for allocation of research funds—are far too high. She is married to Mark Troll, a physical chemist.
Sharon Jayne Peacock is a British microbiologist who is Professor of Public Health and Microbiology in the Department of Medicine at the University of Cambridge. Peacock also sits on Cambridge University Council.
A notifiable disease is one which the law requires to be reported to government authorities.
Judith Glynn is a Professor of Epidemiology at the London School of Hygiene & Tropical Medicine. She worked on the Karonga Prevention Study on HIV and Tuberculosis in Malawi. She is also a sculptor.
Gordon Akanzuwine Awandare is a Ghanaian parasitologist and the Pro-Vice Chancellor in charge of Academic and Student Affairs at the University of Ghana. Prior to his appointment in January 2022, He was the founding Director of the West African Center for Cell Biology of Infectious Pathogens (WACCBIP). He is the current chairman of the CKT-UTAS governing council and the Africa Global Editor of the Experimental Biology and Medicine (EBM) journal.
Amit Singh is an Indian microbiologist and an associate professor at the department of microbiology and cell biology of the Indian Institute of Science. A Wellcome-DBT Senior Fellow, Singh is known for his studies on the pathogenesis of Mycobacterium tuberculosis. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development for 2017/18. He was awarded with the prestigious CSIR- Shanti Swarup Bhatnagar award on 2021 for his phenomenal contributions in bio-scientific research. He received the 2021 Shanti Swarup Bhatnagar Prize for Science and Technology in Biological Science.
Henry Charles Mwandumba is an African Professor of Medicine and the Director of the Malawi-Liverpool-Wellcome Programme. He works on the tuberculosis phagosome in the University of Malawi College of Medicine, and serves as President of the Federation of African Immunological Societies. In 2019 Mwandumba was awarded the Royal Society Africa Prize.
Hazel Marguerite Dockrell is an Irish-born microbiologist and immunologist whose research has focused on immunity to the human mycobacterial diseases, leprosy and tuberculosis. She has spent most of her career at the London School of Hygiene and Tropical Medicine, where as of 2020 she is a professor of immunology. She was the first female president of the Royal Society of Tropical Medicine and Hygiene. Jimmy Whitworth of the Wellcome Trust describes her as "a marvellous ambassador for global health and research."
Ayesha Jennifer Verrall is a New Zealand politician, infectious-diseases physician, and researcher with expertise in tuberculosis and international health. She is a Labour Party Member of the New Zealand Parliament and a Cabinet Minister with the roles of Minister of Health and Minister for Research, Science and Innovation. She has worked as a senior lecturer at the University of Otago, Wellington and as a member of the Capital and Coast District Health Board. During the COVID-19 pandemic she provided the Ministry of Health with an independent review and recommendations for its contact-tracing approach to COVID-19 cases.
Christian Happi is a Professor of Molecular Biology and Genomics in the Department of Biological Sciences and the Director of the African Centre of Excellence for Genomics of Infectious Diseases, both at Redeemer’s University. He is known for leading the team of scientists that used genomic sequencing to identify a single point of infection from an animal reservoir to a human in the Ebola outbreak in West Africa. His research focus is on infectious diseases, including malaria, Lassa fever, Ebola virus disease, HIV, and SARS-CoV-2.
Martin Antonio is an Ghanaian Biologist who is Principal Investigator at the Medical Research Council Unit at London School of Hygiene and Tropical Medicine. He is Director of the World Health Organization Centre for New Vaccines Surveillance and leads the West and Central Africa Regional Reference Laboratory for Invasive Bacterial Diseases.